4//SEC Filing
Sandoval Elisabeth 4
Accession 0001209191-21-047412
CIK 0001566044other
Filed
Jul 19, 8:00 PM ET
Accepted
Jul 20, 5:06 PM ET
Size
5.6 KB
Accession
0001209191-21-047412
Insider Transaction Report
Form 4
Sandoval Elisabeth
Director
Transactions
- Award
Stock Options
2021-07-19+20,500→ 20,500 totalExercise: $2.75Exp: 2031-07-19→ Common Stock (20,500 underlying)
Footnotes (1)
- [F1]These options vest over a 12 month period in equal, monthly installments, ending July 19, 2022.
Documents
Issuer
VYNE Therapeutics Inc.
CIK 0001566044
Entity typeother
Related Parties
1- filerCIK 0001632295
Filing Metadata
- Form type
- 4
- Filed
- Jul 19, 8:00 PM ET
- Accepted
- Jul 20, 5:06 PM ET
- Size
- 5.6 KB